Citations 1
Pembrolizumab in combination with epigenetic therapy is safe and active in heavily treated patients with peripheral T‐cell lymphoma and cutaneous T‐cell lymphoma
Roberts, Naomi L., Lister, John , Benani, Nabila Nora, Jain, Salvia , Battaglia, Tammy, Ayers, Emily C. , Williams, Michael E., Pal, Ipsita , Manavalan, John S., O’Connor, Owen A. , Marchi, Enrica , Roberts, N. L., Abdelmalek, M., Portell, Craig A. , Batchala, Prem Pradeep
Hematological Oncology | June 9, 2023 | Volume: 41 | Issue: S2 | Pages: 269-270
